TRYPTOPHAN METABOLITE RATIO PHARMACOGENOMICS AND PHARMACOMETABOLOMICS: SOD2 AS A MARKER FOR SSRI RESPONSE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD).
CLINICAL PHARMACOLOGY & THERAPEUTICS(2015)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
CLINICAL PHARMACOLOGY & THERAPEUTICS(2015)